IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 16 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 231,736 | $58,000 | 0.00% |
| WEDBUSH SECURITIES INC | 86,530 | $22,000 | 0.00% |
| BARCLAYS PLC | 50 | $0 | 0.00% |
| Avantax Planning Partners, Inc. | 74 | $0 | 0.00% |
| VANGUARD GROUP INC | 79,566 | $20,000 | 0.00% |
| UBS Group AG | 33,627 | $8,000 | 0.00% |
| Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
| IFP Advisors, Inc | 95 | $0 | 0.00% |
| Jacobi Capital Management LLC | 125 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $0 | 0.00% |